Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
Condition(s):Plaque PsoriasisLast Updated:December 29, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Plaque PsoriasisLast Updated:December 29, 2016Completed
Condition(s):Subarachnoid Hemorrhage, AneurysmalLast Updated:November 2, 2020Withdrawn
Condition(s):Rheumatoid ArthritisLast Updated:October 8, 2019Recruiting
Condition(s):Lupus Erythematosus, Discoid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Chronic CutaneousLast Updated:February 27, 2019Completed
Condition(s):Arthritis RheumatoidLast Updated:February 13, 2020Completed
Condition(s):Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic ArthritisLast Updated:October 19, 2020Completed
Condition(s):SpondyloarthritisLast Updated:February 4, 2011Unknown status
Condition(s):Healthy Men and WomenLast Updated:October 28, 2015Completed
Condition(s):Ankylosing SpondylitisLast Updated:February 4, 2011Unknown status
Condition(s):Spondylitis, Ankylosing; RecurrenceLast Updated:November 16, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.